Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesia, General | 8 | 2020 | 30 | 2.220 |
Why?
|
| Anesthesia | 5 | 2014 | 26 | 1.530 |
Why?
|
| Anesthesiology | 4 | 2012 | 19 | 1.200 |
Why?
|
| Intubation, Intratracheal | 2 | 2014 | 27 | 0.730 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2020 | 1 | 0.660 |
Why?
|
| Neuroma | 1 | 2020 | 5 | 0.650 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 9 | 0.650 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 15 | 0.650 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 39 | 0.630 |
Why?
|
| Pediatrics | 2 | 2012 | 92 | 0.590 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 2017 | 3 | 0.530 |
Why?
|
| Secondary Prevention | 1 | 2017 | 46 | 0.520 |
Why?
|
| Patient Positioning | 1 | 2017 | 23 | 0.510 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2017 | 26 | 0.510 |
Why?
|
| Neural Tube Defects | 1 | 2017 | 20 | 0.510 |
Why?
|
| Cesarean Section | 1 | 2017 | 55 | 0.500 |
Why?
|
| Parents | 2 | 2014 | 133 | 0.480 |
Why?
|
| Acetaminophen | 1 | 2015 | 11 | 0.460 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2015 | 8 | 0.460 |
Why?
|
| Medication Errors | 1 | 2015 | 26 | 0.450 |
Why?
|
| Uncertainty | 1 | 2014 | 25 | 0.430 |
Why?
|
| Humans | 31 | 2024 | 28851 | 0.420 |
Why?
|
| Health Education | 1 | 2014 | 75 | 0.410 |
Why?
|
| Anxiety | 1 | 2014 | 158 | 0.390 |
Why?
|
| Child | 11 | 2021 | 2287 | 0.380 |
Why?
|
| Heart Arrest | 2 | 2010 | 27 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 841 | 0.350 |
Why?
|
| Hypercapnia | 1 | 2010 | 5 | 0.340 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 2010 | 3 | 0.340 |
Why?
|
| Male | 19 | 2020 | 13921 | 0.340 |
Why?
|
| Child, Preschool | 10 | 2014 | 1173 | 0.340 |
Why?
|
| Equipment Failure | 1 | 2010 | 31 | 0.340 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 149 | 0.340 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2010 | 1 | 0.330 |
Why?
|
| Diagnostic Errors | 2 | 2008 | 32 | 0.310 |
Why?
|
| Optical Fibers | 1 | 2009 | 5 | 0.300 |
Why?
|
| Lighting | 1 | 2009 | 9 | 0.300 |
Why?
|
| Neck | 1 | 2009 | 26 | 0.300 |
Why?
|
| Infant | 9 | 2012 | 1025 | 0.300 |
Why?
|
| Burns | 1 | 2009 | 17 | 0.300 |
Why?
|
| Propofol | 2 | 2006 | 10 | 0.300 |
Why?
|
| Hyperkalemia | 1 | 2008 | 8 | 0.290 |
Why?
|
| Head Injuries, Penetrating | 1 | 2008 | 4 | 0.290 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 20 | 0.290 |
Why?
|
| Foreign Bodies | 1 | 2008 | 16 | 0.290 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 24 | 0.290 |
Why?
|
| Abnormalities, Multiple | 1 | 2008 | 35 | 0.280 |
Why?
|
| Pneumothorax, Artificial | 1 | 2006 | 1 | 0.250 |
Why?
|
| Health Status | 1 | 2007 | 149 | 0.250 |
Why?
|
| Mediastinal Neoplasms | 1 | 2006 | 11 | 0.250 |
Why?
|
| Methemoglobinemia | 1 | 2005 | 2 | 0.240 |
Why?
|
| Rosaniline Dyes | 1 | 2005 | 8 | 0.240 |
Why?
|
| Coloring Agents | 1 | 2005 | 37 | 0.240 |
Why?
|
| Infusion Pumps | 1 | 2005 | 3 | 0.240 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 126 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 1 | 2024 | 70 | 0.210 |
Why?
|
| Brain | 1 | 2008 | 769 | 0.190 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2006 | 43 | 0.190 |
Why?
|
| Anesthesia, Epidural | 1 | 2022 | 7 | 0.190 |
Why?
|
| Analgesia | 1 | 2021 | 13 | 0.180 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 12 | 0.180 |
Why?
|
| Female | 9 | 2017 | 15624 | 0.160 |
Why?
|
| Infant, Newborn | 2 | 2017 | 916 | 0.160 |
Why?
|
| Spinal Puncture | 3 | 2006 | 11 | 0.150 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 62 | 0.140 |
Why?
|
| Single-Blind Method | 2 | 2014 | 46 | 0.140 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2017 | 2 | 0.130 |
Why?
|
| Supine Position | 1 | 2017 | 4 | 0.130 |
Why?
|
| Sodium Channels | 2 | 2006 | 8 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2024 | 2426 | 0.130 |
Why?
|
| Elective Surgical Procedures | 1 | 2017 | 74 | 0.130 |
Why?
|
| Renal Dialysis | 2 | 2024 | 53 | 0.120 |
Why?
|
| Adult | 3 | 2021 | 8024 | 0.120 |
Why?
|
| Nose | 1 | 2014 | 24 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 40 | 0.110 |
Why?
|
| Language | 1 | 2014 | 65 | 0.110 |
Why?
|
| Barbiturates | 1 | 1993 | 1 | 0.100 |
Why?
|
| Carbachol | 1 | 1993 | 18 | 0.100 |
Why?
|
| Receptors, Cholinergic | 1 | 1993 | 4 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2014 | 1280 | 0.100 |
Why?
|
| Logistic Models | 1 | 2014 | 410 | 0.100 |
Why?
|
| Myoclonus | 1 | 1993 | 2 | 0.100 |
Why?
|
| Morphine | 1 | 1993 | 29 | 0.100 |
Why?
|
| Adolescent | 3 | 2021 | 3193 | 0.100 |
Why?
|
| Pregnancy | 1 | 2017 | 1254 | 0.100 |
Why?
|
| Succinylcholine | 2 | 2008 | 3 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2014 | 463 | 0.090 |
Why?
|
| Drug Administration Routes | 1 | 2012 | 8 | 0.090 |
Why?
|
| Bedding and Linens | 1 | 2012 | 2 | 0.090 |
Why?
|
| Lambert-Eaton Myasthenic Syndrome | 1 | 1992 | 1 | 0.090 |
Why?
|
| Heating | 1 | 2012 | 6 | 0.090 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1992 | 8 | 0.090 |
Why?
|
| Hypothermia | 1 | 2012 | 6 | 0.090 |
Why?
|
| Clinical Competence | 2 | 2012 | 235 | 0.090 |
Why?
|
| Carcinoma, Small Cell | 1 | 1992 | 15 | 0.090 |
Why?
|
| Calcium Channels | 1 | 1992 | 34 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2012 | 997 | 0.080 |
Why?
|
| Ganglia, Spinal | 2 | 2006 | 25 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 94 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 32 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 737 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2010 | 94 | 0.080 |
Why?
|
| Oxygen | 1 | 2010 | 237 | 0.080 |
Why?
|
| Xenon | 1 | 2009 | 1 | 0.080 |
Why?
|
| Equipment Safety | 1 | 2009 | 19 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2006 | 154 | 0.070 |
Why?
|
| Autoantibodies | 1 | 1992 | 481 | 0.070 |
Why?
|
| Posture | 1 | 2008 | 39 | 0.070 |
Why?
|
| Neuromuscular Depolarizing Agents | 1 | 2008 | 2 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2010 | 310 | 0.070 |
Why?
|
| Oklahoma | 1 | 2012 | 1052 | 0.070 |
Why?
|
| Syndrome | 1 | 2008 | 79 | 0.070 |
Why?
|
| American Medical Association | 1 | 2007 | 3 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 1992 | 360 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 67 | 0.070 |
Why?
|
| Demography | 1 | 2007 | 93 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 379 | 0.060 |
Why?
|
| Carbamazepine | 1 | 2006 | 3 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2006 | 20 | 0.060 |
Why?
|
| Neoplasms | 2 | 2007 | 874 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 64 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2006 | 17 | 0.060 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 15 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2006 | 12 | 0.060 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2006 | 3 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2006 | 67 | 0.060 |
Why?
|
| Fentanyl | 1 | 2006 | 35 | 0.060 |
Why?
|
| Methemoglobin | 1 | 2005 | 3 | 0.060 |
Why?
|
| Oximetry | 1 | 2005 | 11 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 60 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2006 | 83 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 69 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2005 | 22 | 0.060 |
Why?
|
| Hypoxia | 1 | 2006 | 90 | 0.060 |
Why?
|
| Radiotherapy | 1 | 2004 | 41 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2007 | 233 | 0.050 |
Why?
|
| Neuromuscular Blockade | 1 | 2024 | 8 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 65 | 0.050 |
Why?
|
| Neurons | 1 | 2006 | 297 | 0.050 |
Why?
|
| Social Support | 1 | 2004 | 129 | 0.050 |
Why?
|
| Brain Neoplasms | 2 | 2000 | 312 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 481 | 0.050 |
Why?
|
| Risk Factors | 1 | 2008 | 2126 | 0.050 |
Why?
|
| Depression | 1 | 2004 | 225 | 0.050 |
Why?
|
| Epidural Space | 1 | 2022 | 11 | 0.050 |
Why?
|
| Needles | 1 | 2022 | 26 | 0.050 |
Why?
|
| Vincristine | 1 | 2002 | 9 | 0.050 |
Why?
|
| Vocal Cord Paralysis | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 377 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2021 | 4 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2002 | 54 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 96 | 0.040 |
Why?
|
| United States | 1 | 2007 | 2222 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 238 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 2000 | 14 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 10684 | 0.040 |
Why?
|
| Liposomes | 1 | 2021 | 145 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 113 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 612 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 254 | 0.040 |
Why?
|
| Torpedo | 2 | 1995 | 2 | 0.030 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 2 | 2006 | 3 | 0.030 |
Why?
|
| Tetrodotoxin | 2 | 2006 | 12 | 0.030 |
Why?
|
| Octanols | 1 | 1995 | 2 | 0.030 |
Why?
|
| Nicotinic Antagonists | 1 | 1995 | 3 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 554 | 0.030 |
Why?
|
| Alcohols | 1 | 1995 | 12 | 0.030 |
Why?
|
| Ion Channels | 1 | 1995 | 28 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 1993 | 67 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 102 | 0.030 |
Why?
|
| Rats | 2 | 2006 | 1588 | 0.020 |
Why?
|
| Tubocurarine | 1 | 1992 | 1 | 0.020 |
Why?
|
| Anesthesia Recovery Period | 1 | 1992 | 2 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2012 | 26 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2012 | 12 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1992 | 10 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 30 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 1992 | 22 | 0.020 |
Why?
|
| Injections, Spinal | 2 | 2002 | 7 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1992 | 26 | 0.020 |
Why?
|
| Remission Induction | 2 | 2002 | 58 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1992 | 256 | 0.020 |
Why?
|
| Platelet Count | 2 | 2002 | 111 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 300 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 19 | 0.020 |
Why?
|
| Electric Capacitance | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2006 | 11 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 31 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2006 | 65 | 0.020 |
Why?
|
| Nociceptors | 1 | 2006 | 42 | 0.020 |
Why?
|
| Bronchial Spasm | 1 | 1986 | 2 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 1986 | 3 | 0.020 |
Why?
|
| Complement C3 | 1 | 1986 | 21 | 0.020 |
Why?
|
| Action Potentials | 1 | 2006 | 196 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2002 | 686 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 485 | 0.010 |
Why?
|
| Pain Threshold | 1 | 2006 | 89 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2002 | 2635 | 0.010 |
Why?
|
| Pain | 1 | 2006 | 258 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 1022 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 138 | 0.010 |
Why?
|
| Aged | 1 | 1992 | 5598 | 0.010 |
Why?
|
| Physical Phenomena | 1 | 2000 | 1 | 0.010 |
Why?
|
| Physics | 1 | 2000 | 2 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 29 | 0.010 |
Why?
|
| African Americans | 1 | 2002 | 352 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 203 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2000 | 266 | 0.010 |
Why?
|
| Heptanol | 1 | 1995 | 1 | 0.010 |
Why?
|
| 1-Octanol | 1 | 1995 | 1 | 0.010 |
Why?
|
| Procaine | 1 | 1995 | 2 | 0.010 |
Why?
|
| Anesthetics | 1 | 1995 | 9 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 1995 | 10 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1995 | 73 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1995 | 106 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 355 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 553 | 0.010 |
Why?
|
| Complement C4a | 1 | 1986 | 3 | 0.000 |
Why?
|
| Complement C5a | 1 | 1986 | 5 | 0.000 |
Why?
|
| Complement C5 | 1 | 1986 | 4 | 0.000 |
Why?
|
| Complement C3a | 1 | 1986 | 6 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1986 | 21 | 0.000 |
Why?
|
| Complement C4 | 1 | 1986 | 16 | 0.000 |
Why?
|
| Complement Activation | 1 | 1986 | 27 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1986 | 68 | 0.000 |
Why?
|
| Middle Aged | 1 | 1986 | 7414 | 0.000 |
Why?
|